Lobar emphysema ratio of more than 1% in the lobe with lung cancer as poor predictor for recurrence and overall survival in patients with stage I non-small cell lung cancer.
Jeong Pyo LeeJae Bum NaHo Cheol ChoiHye Young ChoiJi Eun KimHwa Seon ShinJung Ho WonSa Hong JoSeok Jin HongWon Jeong YangYang Won KimByeong Ju KooIn Seok JangMi-Jung ParkPublished in: PloS one (2023)
A LER of more than 1% in the lobe with lung cancer is a poor predictor for cancer recurrence and overall survival in patients with stage I NSCLC.